MEF2C and central nervous system cancer: In addition, miR-190-5p was also demonstrated to be downregulated in glioma, and overexpression of miR-190-5p inhibited glioma cell growth by targeting myocyte enhancer factor 2C (MEF2C) [20, 28], which functions as a transcription factor of muscle-specific genes during skeletal muscle terminal differentiation [34].